SCHEMBL21650571

SCHEMBL21650571

Cc1nnc(-c2ccn(CCOC(=O)c3ccccc3)c(=O)c2)o1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 10/20 0.46
▸ SMN1; SMN2 Q16637 7/20 0.44
▸ NPC1 O15118 6/20 0.44
▸ RAB9A P51151 6/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21634090 0.85 HDAC6 (0.67) HDAC6SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21634167 0.85 HDAC6 (0.67) HDAC6SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21650573 0.81 HDAC6 (0.53) HDAC6SMN1; SMN2
SCHEMBL21650530 0.77 HDAC6 (0.51) HDAC6SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21650531 0.73 ALDH1A1 (0.47) HDAC6SMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL21650586 0.72 TSHR (0.52) HDAC6NPC1RAB9AALDH1A1MAPT
SCHEMBL21650529 0.71 HDAC6 (0.48) HDAC6RAB9AALDH1A1MAPTKDM4E
SCHEMBL21650589 0.70 HDAC6 (0.52) HDAC6ALDH1A1
SCHEMBL21650562 0.68 HDAC6 (0.56) HDAC6SMN1; SMN2ALDH1A1KDM4EMAPK1
SCHEMBL25017298 0.67 HDAC6 (0.81) HDAC6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3827004-B1 4-(1,3,4-OXADIAZOLE-2-YL)PYRIDINE-2(1H)-ONE DERIVATIVES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS FOR THE TREATMENT OF E.G. INFECTIONS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2023-10-11 — — EP disclosed
WO-2020022794-A1 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2020-01-30 — — WO disclosed
Send feedback